Marshall Islands Healthcare Brief: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Marshall Islands Healthcare Brief.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on February 25, 2026

Feb. 25, 2026

LeMaitre Q4 2025 Financial Results

GlobeNewswire

Feb. 25, 2026

Teladoc Health Reports Fourth Quarter and Full Year 2025 Results

GlobeNewswire

Feb. 25, 2026

Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress

GlobeNewswire

Feb. 25, 2026

PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance

GlobeNewswire

Feb. 25, 2026

Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference

GlobeNewswire

Feb. 25, 2026

Celldex Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

GlobeNewswire

Feb. 25, 2026

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

Feb. 25, 2026

MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

GlobeNewswire

Feb. 25, 2026

Celcuity To Participate in Upcoming Investor Conferences

GlobeNewswire

Feb. 25, 2026

Soleno Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Update on U.S. Launch of VYKAT™ XR

GlobeNewswire

Feb. 25, 2026

Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering

GlobeNewswire

Feb. 25, 2026

Arcutis Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire

$Pritelivir Demonstrates Superior Efficacy in People Living with HIV with Refractory HSV in Phase 3 PRIOH-1$

Feb. 25, 2026

Pritelivir Demonstrates Superior Efficacy in People Living with HIV with Refractory HSV in Phase 3 PRIOH-1

GlobeNewswire

Feb. 25, 2026

Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution

GlobeNewswire

Feb. 25, 2026

ENT & Allergy Associates Announces Plans to Integrate Epic Across Its Network Elevating the Patient Experience and Care Coordination

GlobeNewswire

Feb. 25, 2026

Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030

GlobeNewswire

Feb. 25, 2026

Curaechoice and Fast Pace Health Partner to Expand Affordable Healthcare Access Across Multiple States

GlobeNewswire

Feb. 25, 2026

The Integrated Healthcare Association Recognizes California Provider Organizations for Medicare Advantage Performance

GlobeNewswire

Feb. 25, 2026

SPARK NS Selects Nine Projects to Receive in Total Up to $18 Million in Funding to Advance Academic Discoveries in Autism and Parkinson’s Disease from the Lab to the Clinic

GlobeNewswire

Feb. 25, 2026

Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell

GlobeNewswire